advanced search

Welcome: Guest

log in

aap Implantate AG Product Pipeline Analysis

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 31
ISBN Number not applicable
Product Code GMD04716
Price

£400.00
approximately: $747 | €507

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a aap Implantate AG's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook Orthopedic Devices
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Competitors
  • 6 Key Employees
  • 7 Company Statement
  • 8 Locations And Subsidiaries
    • 8.1 Head Office
    • 8.2 Other Locations & Subsidiaries
  • 9 Recent Developments
    • 9.1 Financial Announcements
      • 9.1.1 Jul 02, 2008: aap Implantate Reports 1H Fiscal 2008 Results
      • 9.1.2 May 14, 2008: aap Implantate Declares Q1 Fiscal 2008 Results
      • 9.1.3 Apr 02, 2008: aap Implantate Declares Fiscal 2007 Results
      • 9.1.4 Nov 12, 2007: aap Implantate Reports Nine-Months Fiscal 2007 Results
      • 9.1.5 Aug 17, 2007: aap Implantate Reports H1 Fiscal 2007 Results
      • 9.1.6 May 31, 2007: aap Implantate Reports Q1 Fiscal 2007 Results
      • 9.1.7 Mar 30, 2007: aap Implantate Reports Fiscal 2006 Results
      • 9.1.8 Nov 03, 2006: aap Implantate Reports Nine-Months Fiscal 2006 Results
      • 9.1.9 Aug 02, 2006: aap Implantate Reports H1 Fiscal 2006 Results
    • 9.2 Corporate Communications
      • 9.2.1 Aug 30, 2007: aap Implantate Elects New Supervisory Board Chairman
    • 9.3 Product News
      • 9.3.1 Jun 11, 2008: CE-Approval For New Orthopaedic Bone Cement Hi-Fatigue G With Antibiotics
    • 9.4 Product Approvals
      • 9.4.1 Jun 11, 2008: CE-Approval For New Orthopaedic Bone Cement Hi-Fatigue G With Antibiotics
  • 10 aap Implantate AG Pipeline Products
    • 10.1 aap Implantate AG Product Pipeline Analysis
      • 10.1.1 aap Implantate AG Pipeline Products By Equipment Type
      • 10.1.2 aap Implantate AG Pipeline Products By Development Stage
      • 10.1.3 aap Implantate AG Pipeline Products By Therapy Area
    • 10.2 Vertolast
      • 10.2.1 Product Description
      • 10.2.2 Product Status
    • 10.3 Bone cements
      • 10.3.1 Product Description
      • 10.3.2 Product Status
    • 10.4 Synthetic bone graft substitutes
      • 10.4.1 Product Description
      • 10.4.2 Product Status
    • 10.5 Urolastic
      • 10.5.1 Product Description
      • 10.5.2 Product Status
  • 11 Appendix
    • 11.1 Methodology
      • 11.1.1 Coverage
      • 11.1.2 Secondary Research
      • 11.1.3 Primary Research
      • 11.1.4 Expert Panel Validation
    • 11.2 Contact Us
    • 11.3 About Global Markets Direct
    • 11.4 Disclaimer
  • 1 List of Tables
    • Table 1: aap Implantate AG,Key Facts
    • Table 2: aap Implantate AG, Key Employees,
    • Table 3: aap Implantate AG, Subsidiaries
    • Table 4: aap Implantate AG Pipeline Products by Equipment Type
    • Table 5: aap Implantate AG Pipeline Products By Development Stage
    • Table 6: aap Implantate AG Pipeline Products By Therapy Area
    • 1.2 List of Figures
    • Figure 1: aap Implantate AG Pipeline Products By Equipment Type
    • Figure 2: aap Implantate AG Pipeline Products By Equipment Type
    • Figure 3: aap Implantate AG Pipeline Products By Development Stage
    • Figure 4: Global Markets Direct Methodology
Product features / use
Scope Expert Insight/Opinion yes
Profiles In-depth Company Insight yes
Features Primary Research Data yes

Industry Events

EuroTIDES

02 Dec 08 to 03 Dec 08
Düsseldorf, Germany
view summary >>

Stability Testing for Biologics

11 Nov 08 to 12 Nov 08
Munich, Germany
view summary >>

Agchemforum

29 Sep 08 to 02 Oct 08
Amsterdam, Netherlands
view summary >>

#